BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 31500789)

  • 21. Breslow Thickness Measurements of Melanomas Around American Joint Committee on Cancer Staging Cut-Off Points: Imprecision and Terminal Digit Bias Have Important Implications for Staging and Patient Management.
    Ge L; Vilain RE; Lo S; Aivazian K; Scolyer RA; Thompson JF
    Ann Surg Oncol; 2016 Aug; 23(8):2658-63. PubMed ID: 27075324
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discordance in the histopathologic diagnosis of melanoma at a melanoma referral center.
    Shoo BA; Sagebiel RW; Kashani-Sabet M
    J Am Acad Dermatol; 2010 May; 62(5):751-6. PubMed ID: 20303612
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expert review remains important in the histopathological diagnosis of cutaneous melanocytic lesions.
    van Dijk MC; Aben KK; van Hees F; Klaasen A; Blokx WA; Kiemeney LA; Ruiter DJ
    Histopathology; 2008 Jan; 52(2):139-46. PubMed ID: 18184263
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinicopathologic study of 85 cases of melanoma of the female genitalia.
    Tcheung WJ; Selim MA; Herndon JE; Abernethy AP; Nelson KC
    J Am Acad Dermatol; 2012 Oct; 67(4):598-605. PubMed ID: 22243767
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An evidence base for reconsidering current follow-up guidelines for patients with cutaneous melanoma less than 0.5 mm thick at diagnosis.
    Einwachter-Thompson J; MacKie RM
    Br J Dermatol; 2008 Aug; 159(2):337-41. PubMed ID: 18510665
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical series of patients with cutaneous melanoma followed-up at the Novara Melanoma Centre from 1983 to 2009: description of the cohort and prognostic factors.
    Miglino B; Pertusi G; Giorgione R; Tiberio R; Astolfi S; Leigheb F; Colombo E
    G Ital Dermatol Venereol; 2013 Oct; 148(5):443-51. PubMed ID: 24005136
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The impact of multidisciplinary team meetings on patient assessment, management and outcomes in oncology settings: A systematic review of the literature.
    Pillay B; Wootten AC; Crowe H; Corcoran N; Tran B; Bowden P; Crowe J; Costello AJ
    Cancer Treat Rev; 2016 Jan; 42():56-72. PubMed ID: 26643552
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Germline BAP1-positive patients: the dilemmas of cancer surveillance and a proposed interdisciplinary consensus monitoring strategy.
    Star P; Goodwin A; Kapoor R; Conway RM; Long GV; Scolyer RA; Guitera P
    Eur J Cancer; 2018 Mar; 92():48-53. PubMed ID: 29413689
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lymphoscintigraphy and sentinel lymph node biopsy, in cutaneous melanoma staging and treatment decisions.
    Jaukovic L; Sijan G; Rajović M; Kandolf-Sekulovic L; Radulovic M; Mijuskovic Z; Zolotarevski L; Ajdinovic B; Novakovic M
    Hell J Nucl Med; 2015; 18(2):146-51. PubMed ID: 26187215
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pathological assessment of tumor biopsy specimen and surgical sentinel lymph node dissection in patients with melanoma.
    Nodiţi G; Nica CC; Petrescu HP; Ivan C; Crăiniceanu ZP; Bratu T; Dema A
    Rom J Morphol Embryol; 2014; 55(3):915-8. PubMed ID: 25329120
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: a multicenter trial. Multicenter Selective Lymphadenectomy Trial Group.
    Morton DL; Thompson JF; Essner R; Elashoff R; Stern SL; Nieweg OE; Roses DF; Karakousis CP; Mozzillo N; Reintgen D; Wang HJ; Glass EC; Cochran AJ
    Ann Surg; 1999 Oct; 230(4):453-63; discussion 463-5. PubMed ID: 10522715
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Data set for pathology reporting of cutaneous invasive melanoma: recommendations from the international collaboration on cancer reporting (ICCR).
    Scolyer RA; Judge MJ; Evans A; Frishberg DP; Prieto VG; Thompson JF; Trotter MJ; Walsh MY; Walsh NM; Ellis DW;
    Am J Surg Pathol; 2013 Dec; 37(12):1797-814. PubMed ID: 24061524
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison of prognostic factors and surgical results in 1,786 patients with localized (stage I) melanoma treated in Alabama, USA, and New South Wales, Australia.
    Balch CM; Soong SJ; Milton GW; Shaw HM; McGovern VJ; Murad TM; McCarthy WH; Maddox WA
    Ann Surg; 1982 Dec; 196(6):677-84. PubMed ID: 7149819
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outcomes and pathological review of a cohort of children with melanoma.
    Leman JA; Evans A; Mooi W; MacKie RM
    Br J Dermatol; 2005 Jun; 152(6):1321-3. PubMed ID: 15949000
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is there a Benefit of Multidisciplinary Cancer Team Meetings for Patients with Gastrointestinal Malignancies?
    Basta YL; Baur OL; van Dieren S; Klinkenbijl JH; Fockens P; Tytgat KM
    Ann Surg Oncol; 2016 Aug; 23(8):2430-7. PubMed ID: 27002814
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Melanoma pathology: important issues for clinicians involved in the multidisciplinary care of melanoma patients.
    Scolyer RA; Prieto VG
    Surg Oncol Clin N Am; 2011 Jan; 20(1):19-37. PubMed ID: 21111957
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early-stage non-Spitzoid cutaneous melanoma in patients younger than 22 years of age at diagnosis: long-term follow-up and survival analysis.
    Stanelle EJ; Busam KJ; Rich BS; Christison-Lagay ER; Dunkel IJ; Marghoob AA; Halpern A; Coit DG; La Quaglia MP
    J Pediatr Surg; 2015 Jun; 50(6):1019-23. PubMed ID: 25819019
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical and pathologic factors associated with distant metastasis and survival in patients with thin primary cutaneous melanoma.
    Murali R; Haydu LE; Long GV; Quinn MJ; Saw RP; Shannon K; Spillane AJ; Stretch JR; Kefford RF; Thompson JF; Scolyer RA
    Ann Surg Oncol; 2012 Jun; 19(6):1782-9. PubMed ID: 22350600
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of elective lymph node dissection in patients with intermediate thickness primary melanoma.
    Reintgen DS; Cox EB; McCarty KS; Vollmer RT; Seigler HF
    Ann Surg; 1983 Sep; 198(3):379-85. PubMed ID: 6615058
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathology of melanocytic lesions: new, controversial, and clinically important issues.
    Scolyer RA; Thompson JF; Stretch JR; Sharma R; McCarthy SW
    J Surg Oncol; 2004 Jul; 86(4):200-11. PubMed ID: 15221927
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.